Víctor Sánchez

Medicine · Health Sciences

8h-index295citations17works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(6), Trypanosoma species research and implications(3), Autism Spectrum Disorder Research(2), Cancer, Hypoxia, and Metabolism(2), Retinal Development and Disorders(2)

Publications17 total

838-P: Reversion of Nonalcoholic Steatohepatitis by Skeletal-Muscle Directed FGF21 Gene Therapy
Diabetes·2023
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
Molecular Therapy — Methods & Clinical Development·2022· 26 citedOpen Access
Caso clínico: beta talasemia y deficiencia de factor VII en embarazo
Revista Chilena de Anestesia·2022· 2 citedOpen Access
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal
Molecular Therapy — Methods & Clinical Development·2021· 31 citedOpen Access
Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
Nature Communications·2021· 35 citedOpen Access
Diagnóstico histopatológico e inmunohistoquímico (IHQ) de linfoma no Hodgkin (LNH) en un canino hembra
Revista de Investigaciones Veterinarias del Perú·2020Open Access
Dolor femoropatelar después de meniscectomía artroscópica: estudio de actividad eléctrica y atrofia de vasto medial
Revista Española de Artroscopia y Cirugía Articular·2019Open Access
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain
Open Forum Infectious Diseases·2019· 9 citedOpen Access
Bioarchaeology to bring back scents from extinct plants - Review
Archaeobios·2019· 1 cited
Evolución desde los primeros homínidos a los humanos modernos: filosofía, bioarqueología y biología - Revisión
Archaeobios·2018
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID
Human Molecular Genetics·2017· 50 citedOpen Access
Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC
Disease Models & Mechanisms·2016· 27 citedOpen Access
CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
JCI Insight·2016· 61 citedOpen Access
348. Correction of CNS and Somatic Pathology by Intra-Cerebrospinal Fluid Gene Therapy for Mucopolysaccharidosis Type II
Molecular Therapy·2016Open Access
ribera et al 2015 supp mat
2015
Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy
Human Molecular Genetics·2014· 53 citedOpen Access
Morphotypes and Breeds of dogs
Archaeobios·2009

Frequent Co-authors

Fátima Bosch(10), Miquel García(9), Sara Marcó(9), Albert Ribera(9), Xavier León(9), Virginia Haurigot(7), Maria Molas(7), Jesús Ruberte(7), Sandra Motas(6), Carles Roca(6), Xavier Sánchez(6), Joan Bertolin(5), Pilar Villacampa(4), Luca Maggioni(3), Sergio Muñoz(3), Martı́ Pumarola(3), Sònia Añor(3), Jennifer Pérez(3), Anna Pujol(3), Maria Luisa Jaén(3)